Botanix Pharmaceuticals BXPHF Stock
Botanix Pharmaceuticals Price Chart
Botanix Pharmaceuticals BXPHF Financial and Trading Overview
| Botanix Pharmaceuticals stock price | 0.02 USD |
| Previous Close | 0.02 USD |
| Open | 0.02 USD |
| Bid | 0.01 USD x 14586600 |
| Ask | 0.04 USD x 11000000 |
| Day's Range | 0.02 - 0.02 USD |
| 52 Week Range | 0.01 - 0.13 USD |
| Volume | 45K USD |
| Avg. Volume | 12.25K USD |
| Market Cap | 45.98M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.02 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
BXPHF Valuation Measures
| Enterprise Value | 4.09M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.3169161 |
| Price/Book (mrq) | 0.8665082 |
| Enterprise Value/Revenue | 0.117 |
| Enterprise Value/EBITDA | -0.062 |
Trading Information
Botanix Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -83.20% |
| S&P500 52-Week Change | 19.66% |
| 52 Week High | 0.13 USD |
| 52 Week Low | 0.01 USD |
| 50-Day Moving Average | 0.02 USD |
| 200-Day Moving Average | 0.04 USD |
BXPHF Share Statistics
| Avg. Volume (3 month) | 12.25K USD |
| Avg. Daily Volume (10-Days) | 5.61K USD |
| Shares Outstanding | 2.74B |
| Float | 2.27B |
| Short Ratio | N/A |
| % Held by Insiders | 9.59% |
| % Held by Institutions | 10.12% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2026 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | June 30, 2027 |
Profitability
| Profit Margin | -199.84% |
| Operating Margin (ttm) | -187.89% |
| Gross Margin | 58.90% |
| EBITDA Margin | -188.71% |
Management Effectiveness
| Return on Assets (ttm) | -36.26% |
| Return on Equity (ttm) | -96.35% |
Income Statement
| Revenue (ttm) | 34.91M USD |
| Revenue Per Share (ttm) | 0.02 USD |
| Quarterly Revenue Growth (yoy) | 152.50% |
| Gross Profit (ttm) | 20.56M USD |
| EBITDA | -65884048 USD |
| Net Income Avi to Common (ttm) | -69768608 USD |
| Diluted EPS (ttm) | -0.03 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 36.63M USD |
| Total Cash Per Share (mrq) | 0.02 USD |
| Total Debt (mrq) | 916.82K USD |
| Total Debt/Equity (mrq) | 1.44 USD |
| Current Ratio (mrq) | 2.591 |
| Book Value Per Share (mrq) | 0.01938816 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -64596524 USD |
| Levered Free Cash Flow (ttm) | -32246572 USD |
Profile of Botanix Pharmaceuticals
| Country | United States |
| State | WA |
| City | Melbourne |
| Address | Tower 5, Collins Square |
| ZIP | 3008 |
| Phone | 61 8 6555 2945 |
| Website | https://www.botanixpharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Botanix Pharmaceuticals Limited, a pharmaceutical company, engages in the research and commercialization of solutions for skin diseases and infections in Australia and the United States. The company's lead product is Sofdra (sofpironium) topical gel, a prescription anticholinergic medicine used to treat underarm sweating in adults and children 9 years of age and older. It also develops BTX 1503, a transdermal gel formulation, which is in Phase 3 clinical trial for the treatment of serious acne in adults and teenagers; BTX 1702 that is in Phase 1b/2 clinical trial to treat papulopustular rosacea; BTX 1204A for treating atopic dermatitis; and BTX 1801, which has been completed Phase 2a clinical trial for the treatment of staphylococcus aureus and methicillin resistant staphylococcus aureus. The company was incorporated in 1984 and is based in Melbourne, Australia.
Q&A For Botanix Pharmaceuticals Stock
What is a current BXPHF stock price?
Botanix Pharmaceuticals BXPHF stock price today per share is 0.02 USD.
How to purchase Botanix Pharmaceuticals stock?
You can buy BXPHF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Botanix Pharmaceuticals?
The stock symbol or ticker of Botanix Pharmaceuticals is BXPHF.
Which industry does the Botanix Pharmaceuticals company belong to?
The Botanix Pharmaceuticals industry is Biotechnology.
How many shares does Botanix Pharmaceuticals have in circulation?
The max supply of Botanix Pharmaceuticals shares is 2.74B.
What is Botanix Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Botanix Pharmaceuticals PE Ratio is now.
What was Botanix Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Botanix Pharmaceuticals EPS is -0.02 USD over the trailing 12 months.
Which sector does the Botanix Pharmaceuticals company belong to?
The Botanix Pharmaceuticals sector is Healthcare.
